Impact of Pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis

Back

EHRA Premium Access

Impact of Pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis

Session: Arrhythmias 3: atrial fibrillation

Topic: Prevention

Speaker: Doctor S. Im (Pusan, KR)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Sung Il Im

kosin university gospel hospital, Pusan (Korea (Republic of))

0 follower

7 more presentations in this session

Unfolding the transition ratio: insight into the diagnostic criteria for the diagnosis of the origin of outflow tract ventricular arrhythmias.

Speaker: Doctor L. Lazzari (Terni, IT)

Feasibility and diagnostic yield of a photoplethysmography-based arrhythmia screening and integrated management pathway in a chronic obstructive pulmonary disease outpatient clinic

Speaker: Miss M. Hereijgers (Maastricht, NL)

Photoplethysmography recordings preceding onset atrial fibrillation show a higher heart rate variability - a TeleCheck-AF subanalysis

Speaker: Doctor H. Hillmann (Hannover, DE)

Diagnostic accuracy of smartwatches for automated atrial fibrillation detection over time: insights from the basel wearable study

Speaker: Ms C. Isenegger (Basel, CH)

Clinical findings and outcomes of Brugada syndrome in women

Speaker: Mr M. Kruska (Mannheim, DE)

Access the full session

Arrhythmias 3: atrial fibrillation

Speakers: Doctor S. Im, Doctor L. Lazzari, Miss M. Hereijgers, Doctor H. Hillmann, Ms C. Isenegger...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources